Back

Helminth-derived metabolites induce tolerogenic functional, metabolic, and transcriptional signatures in dendritic cells that attenuate experimental colitis

Malacco, N. L.; Michi, A. N.; Siciliani, E.; Madrigal, A. G.; Sternlieb, T.; Fontes, G.; King, I. L.; Cestari, I.; Jardim, A.; Stevenson, M. M.; Lopes, F.

2023-01-26 immunology
10.1101/2023.01.26.525718 bioRxiv
Show abstract

Helminth infections can restore immune tolerance and suppress intestinal inflammation, yet the molecular mediators underlying these effects are poorly defined. Here, we show that nonpolar metabolites derived from the helminth Heligmosomoides polygyrus bakeri (HnpM) program dendritic cells (DCs) toward a tolerogenic DC (tolDC) phenotype. Adoptive transfer of HnpM-treated DCs significantly ameliorated DSS-induced intestinal inflammation in mice. Transcriptomic and metabolomic profiling revealed that HnpM induces early metabolic reprogramming followed by gene expression signatures characteristic of tolerogenic DCs that are shared by established tolDC-inducing agents. Together, these findings identify that helminth-derived metabolites are a novel source of small molecule therapeutics to restore immune tolerance in immune-mediated disorders. Summary SentenceMetabolites produced by Heligmosomoides polygyrus induce metabolic and transcriptional changes in DCs consistent with tolDCs, and adoptive transfer of these DCs attenuate DSS-induced intestinal inflammation.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.